CAR T-cell therapy, also known as Chimeric Antigen Receptor T-cell therapy, is a personalized form of immunotherapy treatment that genetically modifies a patient’s immune system to target and destroy cancer cells. It is used to treat some types of blood cancer, including multiple myeloma.
The success of CAR T-cell therapy is promising with significant remission rates in patients who have not responded to standard cancer treatments.
Dr. Laura Finn is the section chair of hematology at Ochsner MD Anderson Cancer Center. She received her medical degree from Louisiana State University School of Medicine in New Orleans before completing her residency in internal medicine at Earl K. Long at LSU in Baton Rouge.
Finn went on to a hematology and oncology fellowship at Mayo Clinic School of Graduate Medical Education in Jacksonville, Florida. She also completed advanced training in stem cell transplant as a Mayo Clinic Scholar at the University of Minnesota.…